1.
Vishwakarma P, Kumar A, Sharma M, Garg M, Saxena K. Histone deacetylase inhibitors: pharmacotherapeutic implications as epigenetic modifier. Int J Basic Clin Pharmacol [Internet]. 2017 Jan. 23 [cited 2024 Oct. 16];3(1):27-36. Available from: https://www.ijbcp.com/index.php/ijbcp/article/view/941